Threshold Pharma (THLD) Posts Q4 Loss of 12c/Share
Tweet
Share
E-mailGet Alerts THLD Hot Sheet
Price: $0.54 --0%
Financial Fact:
Loss from operations: -5.24M
Today's EPS Names:
EPAC, SAR, KRUS, More
Financial Fact:
Loss from operations: -5.24M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Threshold Pharma (NASDAQ: THLD) reported Q4 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $4.1 million.
For earnings history and earnings-related data on Threshold Pharma (THLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
- UBS Reiterates Buy Rating on Smurfit Westrock (SW)
- DigitalOcean projects record Q2 2026 results with RPO above $800M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
